Thermi Receives Notice of Complete and Satisfactory Closure of FDA’s “Vaginal Rejuvenation” Inquiry

IRVING, TEXAS (November 15, 2018) – Thermi®, an Almirall, S.A. company, today announced that it has received a notice of completion to a U.S. Food and Drug Administration (FDA) inquiry on products used in “vaginal rejuvenation” procedures. Th...

What is the O-Shot? Is it for me?

As women age, some may find that sexual pleasure is increasingly difficult to at...

Dr. Andrea Pezzella Named Fellow at AIAVS

Dr. Andrea Pezzella has recently completed her training under Dr. Red M. Alinsod...

Is the InterStim Right for Me?

Urinary incontinence is a condition that can affect your life in many ways, such...

The Power of Minimally Invasive Surgery

Thanks to advancements in medical science and technology, surgical procedures th...

Exercising with Stress Incontinence

1 in 10 women over the age of 65 experience urinary or stress incontinence, whic...

Should You Have a Labiaplasty?

Some women may find that their labia minora (the lips at the opening of the vagi...

Treatment Options for a Pelvic Floor Prolapse

What is a pelvic floor prolapse? A pelvic floor prolapse is a condition in which...

Lichen sclerosus: Can it affect you?

As you get older, there are certain conditions that tend to be a little bit more...